RSV Prevention Products Tied to Fewer Kids’ Hospital Visits

by | Apr 17, 2026 | Health

Spread the love
The combined use of nirsevimab and maternal respiratory syncytial virus vaccine is linked to a lower burden of severe RSV infection among infants aged 7 months or younger in Washington state.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments